Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025

乳房再建の世界市場予測(~2025):製品別、処置別、種類別、エンドユーザー別

◆タイトル:Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025
◆商品コード:MD 7670
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年6月4日
◆ページ数:137
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥529,650見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は乳房再建の世界市場が2020年4億3,000万ドルから2025年6億3,000万ドルまで、年平均7.0%成長すると見込んでいます。本調査レポートでは、乳房再建の世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(豊胸手術、組織エキスパンダー、無細胞皮膚マトリックス)分析、処置別分析、種類別分析、エンドユーザー別分析、地域別分析、競争状況、企業概要などを含め、提供しております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・乳房再建の世界市場規模:製品別(豊胸手術、組織エキスパンダー、無細胞皮膚マトリックス)
・乳房再建の世界市場規模:処置別
・乳房再建の世界市場規模:種類別
・乳房再建の世界市場規模:エンドユーザー別
・乳房再建の世界市場規模:地域別
・競争状況
・企業概要

“The global breast reconstruction market is projected to register a CAGR of 7.0% during the forecast period.”
The global breast reconstruction market size is projected to reach USD 603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0%. Growth in this industry is driven by the rising incidences of breast cancer, increasing awareness, and the availability of reimbursements. However, clinical risks and complications associated with breast reconstruction restrain the market growth.

“The acellular dermal matrix segment is anticipated to grow at the fastest growth rate during the forecast period.”
The breast reconstruction market, by product, is categorized into breast implants, tissue expanders, and acellular dermal matrix. The acellular dermal matrix segment is expected to register the highest CAGR during the forecast period. The growth of this segment is mainly driven by the rising incidences of breast cancer, increasing number of mastectomies, and growing use usage of acellular dermal matrices.

“The immediate procedure segment is estimated to grow at a rapid rate during the forecast period.”
On the basis of procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. Immediate procedures are expected to remain the fastest-growing segment of the global breast reconstruction market during the breast reconstruction period. Factors such as the increasing number of surgeries post-mastectomy and rising awareness are driving the market.

“Asia Pacific is estimated to register the highest CAGR during the study period.”
Geographically, the breast reconstruction market is dominated by North America and Europe. However, the Asia Pacific market is estimated to grow at the fastest rate during the forecast period.

Breakdown of Profiles of Primary Participants:
• By Company Type: Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation: C-level: 30%, Director-level: 34%, and Others: 36%
• By Region: North America: 40%, Europe: 28%, Asia Pacific: 20%, and the Rest of the World: 12%

The key players in the breast reconstruction market include Johnson & Johnson (US), Allergan (Ireland), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), Polytech Health & Aesthetics (Germany), Sientra (US), and .

Research Coverage:
The report analyzes the breast reconstruction market by product, procedure, type, end user, and region. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, changes in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:
This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use either or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the products of the top players in the breast reconstruction market
• Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of the leading players in the breast reconstruction market
• Market Development: Detailed information about emerging markets
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the breast reconstruction market

【レポートの目次】

1 INTRODUCTION (Page No. – 17)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 20)
2.1 RESEARCH DATA
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.4 MARKET SIZE ESTIMATION
2.4.1 BOTTOM-UP APPROACH
2.4.2 GROWTH FORECAST
2.4.3 TOP-DOWN APPROACH
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. – 27)

4 PREMIUM INSIGHTS (Page No. – 31)
4.1 BREAST RECONSTRUCTION: MARKET OVERVIEW
4.2 NORTH AMERICA: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2019
4.3 GEOGRAPHICAL SNAPSHOT OF THE BREAST RECONSTRUCTION MARKET

5 MARKET OVERVIEW (Page No. – 33)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising incidence of breast cancer
5.2.1.2 Increasing awareness
5.2.1.3 Reimbursements for breast reconstruction
5.2.2 RESTRAINTS
5.2.2.1 Clinical risks and complications of breast reconstruction procedures
5.2.2.2 Alternative non-surgical methods
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging markets
5.2.3.2 Development of 3D-printed implants
5.2.4 CHALLENGES
5.2.4.1 Product failures and recalls
5.3 PRICING ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM
5.5.1 COVID-19 IMPACT ON THE BREAST RECONSTRUCTION MARKET

6 BREAST RECONSTRUCTION MARKET, BY PRODUCT (Page No. – 39)
6.1 INTRODUCTION
6.2 BREAST IMPLANTS
6.2.1 BREAST IMPLANTS MARKET, BY TYPE
6.2.1.1 Silicone implants
6.2.1.1.1 Silicone breast implants to dominate the breast implants market during the forecast period
6.2.1.2 Saline implants
6.2.1.2.1 Low cost of implants to drive market growth
6.2.2 BREAST IMPLANTS MARKET, BY SHAPE
6.2.2.1 Round implants
6.2.2.1.1 Round implants show the highest end-user demand and market growth
6.2.2.2 Anatomical implants
6.2.2.2.1 Increasing implant-based breast reconstruction procedure will support the market growth
6.3 TISSUE EXPANDERS
6.3.1 RISING NUMBER OF BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH
6.4 ACELLULAR DERMAL MATRIX
6.4.1 RISING NUMBER OF ACELLULAR DERMAL MATRIX BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH

7 BREAST RECONSTRUCTION MARKET, BY PROCEDURE (Page No. – 46)
7.1 INTRODUCTION
7.2 IMMEDIATE PROCEDURES
7.2.1 IMMEDIATE PROCEDURES HOLD LARGEST MARKET SHARE
7.3 DELAYED PROCEDURES
7.3.1 RISING AWARENESS WILL SUPPORT MARKET GROWTH
7.4 REVISION PROCEDURES
7.4.1 DISSATISFACTION AND AESTHETIC ISSUES DRIVE DEMAND FOR REVISION

8 BREAST RECONSTRUCTION MARKET, BY TYPE (Page No. – 50)
8.1 INTRODUCTION
8.2 UNILATERAL BREAST RECONSTRUCTION
8.2.1 UNILATERAL RECONSTRUCTION DOMINATES THE MARKET, BY TYPE
8.3 BILATERAL
8.3.1 APAC TO SHOW HIGHEST GROWTH IN THE MARKET FOR BILATERAL BREAST RECONSTRUCTION

9 BREAST RECONSTRUCTION MARKET, BY END USER (Page No. – 53)
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 HOSPITALS TO DOMINATE THE BREAST RECONSTRUCTION MARKET DURING THE FORECAST PERIOD
9.3 COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS
9.3.1 GROWING PREFERENCE FOR OUTPATIENT TREATMENT AND PROCEDURES OVER HOSPITAL CARE DRIVES MARKET GROWTH
9.4 COVID-19 ANALYSIS

10 BREAST RECONSTRUCTION MARKET, BY REGION (Page No. – 56)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 The US dominates the North American breast reconstruction market
10.2.2 CANADA
10.2.2.1 Increasing incidence of breast cancer will drive market growth in Canada
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Germany dominates the European breast reconstruction market
10.3.2 FRANCE
10.3.2.1 Rising geriatric population will drive market growth
10.3.3 UK
10.3.3.1 Rising incidences of breast cancer will support market growth
10.3.4 ITALY
10.3.4.1 Rising geriatric population in Italy to drive the market
10.3.5 SPAIN
10.3.5.1 R&D investments for the development of innovative drugs form a key growth driver in the Spanish market
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 China accounts for the largest share of the APAC market
10.4.2 JAPAN
10.4.2.1 Growing geriatric population to drive the market in Japan
10.4.3 INDIA
10.4.3.1 Market growth in India is primarily driven by the rising incidence of breast cancer
10.4.4 REST OF ASIA PACIFIC
10.5 REST OF THE WORLD

11 COMPETITIVE LANDSCAPE (Page No. – 96)
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS, 2019
11.3 COMPETITIVE SCENARIO
11.3.1 PRODUCT LAUNCHES AND APPROVALS
11.3.2 PARTNERSHIPS, COLLABORATIONS, MERGERS, AND AGREEMENTS
11.3.3 EXPANSIONS
11.3.4 ACQUISITIONS
11.3.5 OTHER DEVELOPMENTS
11.4 COMPETITIVE LEADERSHIP MAPPING (2018)
11.4.1 VISIONARY LEADERS
11.4.2 INNOVATORS
11.4.3 DYNAMIC DIFFERENTIATORS
11.4.4 EMERGING COMPANIES

12 COMPANY PROFILES (Page No. – 103)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 JOHNSON & JOHNSON
12.2 ALLERGAN
12.3 SIENTRA
12.4 POLYTECH HEALTH & AESTHETICS
12.5 GC AESTHETICS
12.6 SEBBIN
12.7 IDEAL IMPLANT INCORPORATED
12.8 ESTABLISHMENT LABS S.A.
12.9 INTEGRA LIFESCIENCES
12.10 LABORATORIES ARION
12.11 SILIMED
12.12 GUANGZHOU WANHE PLASTIC MATERIALS
12.13 CEREPLAS
12.14 HANSBIOMED
12.15 RTI SURGICAL HOLDINGS
12.16 SHANGHAI KANGNING MEDICAL DEVICE
12.17 PMT CORPORATION



★調査レポート[乳房再建の世界市場予測(~2025):製品別、処置別、種類別、エンドユーザー別] ( Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025 / MD 7670) 販売に関する免責事項
[乳房再建の世界市場予測(~2025):製品別、処置別、種類別、エンドユーザー別] ( Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025 / MD 7670) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆